EPIC: an effective low toxicity regimen for relapsing lymphoma.

We have treated 40 patients was relapsed or resistant lymphoma with the combination of Etoposide, Prednisolone, Ifosfamide and Cisplatin (EPIC). Complete response was obtained in 11 patients (28%) with an overall response of 58%. The presence of bulky disease (P < 0.005), elevated LDH serum level...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickish, T., Roldan, A., Cunningham, D., Mansi, J., Ashley, S., Nicolson, V., Gore, M. E., Catovsky, D., Smith, I. E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968387/
https://www.ncbi.nlm.nih.gov/pubmed/8353050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968387/
https://www.ncbi.nlm.nih.gov/pubmed/8353050

Ejemplares similares